Environment

A01

Gut microbiome metabolites in MS inflammation and neurodegeneration

Univ.-Prof. Dr. med. Aiden Haghikia
Universitätsklinik für Neurologie
Magdeburg

Univ.-Prof. Dr. med. Ralf Gold
Universitätsklinik für Neurologie
Bochum

 

A08

Impact of diet and intestinal microbiota on the gut-CNS axis – implication for CNS autoimmunity

Univ.-Prof. Dr. med. Luisa Klotz
Klinik für Neurologie mir Institut für Translationale Neurologie
Münster

Prof. Dr. med. Dr.rer.nat. Detlef Schuppan
Institut für Translationale Immunologie, Forschungszentrum Immuntherapie
Mainz

 

A10

Skin-sensing of environmental factors and their impact on the development of multiple sclerosis

Univ.-Prof. Dr. med. Karin Loser
Zentrum für Experimentelle Dermatologie und Immunbiologie der Haut
Oldenburg

Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more